Transformation Manager Order-2-Cash Europe (jun./sen.) (m/f/d)

Eurofins Genomics is globally known for its innovative and customized technologies in the life science industries and academic research.

We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression analysis, Sanger sequencing, oligonucleotide, and gene synthesis.

Being passionate about our strong customer orientation, our service and quality standards is our highest priority.

We are an entrepreneurial organization with a dynamic international management team, continuously seeking for new growth opportunities.

We encourage our employees to take responsibility and offer personal leeway for shaping the future of the company.

To further strengthen our Team & processes, we are looking for a dynamic and passionate person to fulfill the newly created position of Transformation Manager Order-2-Cash Europe (m / f / d).

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable.

From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.

Eurofins believes it is a global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services.

It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies.

In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 62,000 staff across a network of more than over 1000 independent companies in over 62 countries and operating more than 900 laboratories.

Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.

In 2023, Eurofins generated total revenues of EUR € 6.515 billion, and has been among the best performing stocks in Europe over the past 20 years.

TLNT1 DE